Lisbon is a useful place to start an investor search, not a reason to approach every Portuguese fund. A software team with its first customers, an ocean-technology company and a therapeutic-biotech spinout need different evidence and different partners. This guide separates those routes so you can build a shortlist you can actually use.
Compare 15 provider families, including 10 documented local or regional routes. Start with the decision framework, use the comparison to screen candidates and save the evidence in the worksheet before you approach anyone.
Choose the Lisbon funding route that fits your next milestone
| Your situation | Research first | Prepare or clarify |
|---|---|---|
| First software product or customer validation | Compare Bynd, LC Ventures, the appropriate Shilling route and COREangels Lisbon. | Document the Iberian or Portuguese operating connection, product state and next test. |
| Applied science, climate or ocean technology | Research Faber and the relevant Indico or EDP Ventures strategy. | Connect technical evidence with a customer, deployment or commercialization milestone. |
| Therapeutic biotech | Check Biovance’s seed/Series-A criteria. | Prepare the actual therapeutic asset and preclinical evidence, not a generic digital-health pitch. |
| Series A industrial or vertical software growth | Compare Semapa Next with the appropriate wider technology funds. | Bring commercial evidence and a precise expansion plan. |
Choose a small first wave you can research properly. Record one reason for fit, one relevant proof point and the next unanswered question for each investor. Move a name out of the active queue when the stage, sector or geographic conditions do not fit.
Compare 15 local and wider investor routes
The connection column distinguishes a documented city or regional route from a wider mandate. It does not imply that every provider has an office here. Initial investment stages and follow-on support are different. This selective list is unranked; each provider family counts once.
| Investor or network | Connection | Entry-stage distinction | Company focus |
|---|---|---|---|
| Indico Capital Partners | Local / regional: Lisbon team; Portugal, Spain and Italy connections | Mostly pre-seed to Series A | Technology; ocean and sustainability |
| Armilar | Local / regional: Lisbon office; wider technology mandate | Pre-seed to Series B; vehicle-specific | Enterprise and other technology |
| Faber | Local / regional: Lisbon base; Southern Europe and selected Europe | Pre-seed and seed | Applied science; digital transformation; climate and ocean |
| Bynd Venture Capital | Local / regional: Lisbon office; Iberian founders or teams | Pre-seed and seed | AI/software; consumer; sustainability technology |
| LC Ventures | Local / regional: Lisbon; fund-specific Portuguese operating criteria | Pre-seed and seed | Software and innovative ICT |
| Biovance Capital | Local / regional: Lisbon and Porto offices; European investing | Seed and Series A | Therapeutic biotechnology |
| Shilling | Wider route: Portuguese founder-backed network; verify current team | Early technology investment; confirm round | Scalable technology-driven businesses |
| Portugal Ventures | Wider route: Portugal-wide; registered-office criteria | Pre-seed, seed and Series A | Digital technology; manufacturing; healthcare and other calls |
| EDP Ventures | Local / regional: Lisbon investment-team presence; international energy remit | Early-stage energy technology | Energy transition technology |
| Bright Pixel Capital | Wider route: Portugal-based platform; international technology | Seed/early and other strategies; confirm vehicle | Cybersecurity; infrastructure software; business applications |
| 2bpartner | Wider route: Portuguese regional vehicles; confirm Lisbon eligibility | Early-stage; vehicle-specific | Innovative companies with international growth potential |
| Semapa Next | Local / regional: Lisbon base; pan-European | Series A | Industrial technology; supply chain/logistics; energy transition; vertical software |
| MSM | Local / regional: Lisbon office; European companies | Early venture; confirm current entry round | Businesses aligning commercial and social/environmental outcomes |
| COREangels Lisbon | Local / regional: Portuguese ecosystem connection | Pre-seed and seed | Early startups with coachable teams |
| Seedcamp | Wider route: European founders; not a Lisbon office | Earliest stages | Technology startups |
What are the venture capital funds available in Portugal?
Portugal has several investment lanes, not one universal startup fund. This Lisbon selection includes local technology teams, a therapeutic-biotech specialist, an angel group, corporate energy investment and national or European alternatives. The Portugal venture-capital guide remains the national overview. Here, the useful addition is the decision between a Lisbon relationship and the actual company, sector and vehicle criteria.
Bynd’s Iberian founder/team screen and LC Ventures’ vehicle-specific operating regions illustrate why an office address is not enough. Write down where the team operates, which company is raising and what the proposed round should prove before choosing a route.
Lisbon software, ocean technology and biotech need different proof
A software company can explain product use, customer learning and commercial distribution. A frontier-technology company also needs to explain what has been technically demonstrated and what development risk remains. A therapeutic company needs a different evidence package again. Treat these as different financing conversations, not interchangeable sector tags.
Faber’s current focus separates applied science, digital transformation, climate and ocean technology. Biovance’s criteria describe therapeutic biotech and appropriate preclinical evidence. For energy technology, explain an independent business case as well as any possible corporate deployment. A commercial pilot does not imply investment approval.
Use founder submissions, not the fund-investor enquiry
Many Lisbon investment websites serve founders and people investing into the funds. Indico explicitly separates its company-investment route from institutional and individual investor enquiries. Armilar, Shilling and Bynd also publish founder pitch routes. Start with the right form and include a short company explanation, current evidence, round and proposed milestone.
If a founder, customer or researcher can genuinely introduce you, ask permission and provide a concise forwardable note. Otherwise, use the public route. Finta helps keep the fit evidence, relationship context and next action together; it does not turn a directory entry into guaranteed access.
15 investors and networks to research
1. Indico Capital Partners
Technology and sustainability VC. Indico is useful when a Lisbon company has a credible route from its first market into a larger one. Its founder page separates early MVP or pilot evidence from later customer metrics. Explain the Portuguese, Spanish or Italian connection and select the relevant technology or ocean strategy.
Approach: Use Get Investment, not the separate investor/LP enquiry. Official Indico Capital Partners information. Additional criteria or geographic context.
2. Armilar
Technology VC. Armilar provides a local research starting point for a technology business, but a Lisbon office is not the complete investment test. Connect the product’s technical advantage with the relevant investment team, current company evidence and proposed round. Its official site includes a dedicated pitch route.
Approach: Use Submit pitch in Why Armilar. Official Armilar information. Additional criteria or geographic context.
3. Faber
Deep-tech VC. Faber’s specialist focus makes the scientific or technical milestone more important than a broad startup label. A Lisbon ocean-technology or applied-science team should explain what has been demonstrated, what remains uncertain and which customer or deployment test the round will enable.
Approach: Use the relevant focus and team information. Official Faber information. Additional criteria or geographic context.
4. Bynd Venture Capital
Pre-seed and seed VC. Bynd explicitly looks for an Iberian founder or team connection. For a Lisbon startup, show where the team operates and how early product or customer evidence supports the next step. Distinguish its first professional investment proposition from later follow-on capacity.
Approach: Use Submit your pitch on the official site. Official Bynd Venture Capital information. Additional criteria or geographic context.
5. LC Ventures
Pre-seed and seed VC. LC Ventures can fit a software-led team that values engineering and operating support. Its vehicles have different Portuguese regional criteria, so do not assume every vehicle treats a Lisbon company identically. Prepare the software product, relevant operations and next validation milestone before applying.
Approach: Use Apply and confirm the specific vehicle. Official LC Ventures information. Additional criteria or geographic context.
6. Biovance Capital
Biopharma VC. Biovance belongs in a therapeutic-biotech shortlist, not a generic digital-health queue. A Lisbon research team should prepare the asset, appropriate preclinical evidence and intellectual-property position for the firm’s stated criteria. The company is the relevant current investment route; do not add the former Bionova operation as another investor.
Approach: Use Contacts after checking About criteria. Official Biovance Capital information. Additional criteria or geographic context.
7. Shilling
Founder-backed VC. Shilling’s founder-backed model is relevant when operating experience could help the company’s next milestone. Its pitch screen asks about the solution, scalability and balanced team. Make the request specific: what has the Lisbon team learned, and what would a first institutional partner help prove?
Approach: Use Pitch to us. Official Shilling information. Additional criteria or geographic context.
8. Portugal Ventures
VC. Portugal Ventures is a national investment route rather than a Lisbon-only fund. Check the current call and company criteria, then connect the round to a defined product, manufacturing or commercial milestone. Keep this equity research separate from grant applications and other public support.
Approach: Review the current calls and investment strategy. Official Portugal Ventures information.
9. EDP Ventures
Corporate VC. A Lisbon energy startup should separate the investment case from a potential pilot inside EDP’s operating ecosystem. Show the independent commercial value and what a deployment would demonstrate. EDP Ventures’ international mandate means a Portuguese location is context, not the entire reason for fit.
Approach: Use the venture-investments team and contact information. Official EDP Ventures information.
10. Bright Pixel Capital
Technology investment platform. Bright Pixel is a wider specialist route for a Lisbon software team. Start with the relevant investment theme and current team, not a general Portuguese connection. Prepare the customer problem, technical differentiation and evidence that makes the proposed financing stage appropriate.
Approach: Use the official Contact route. Official Bright Pixel Capital information. Additional criteria or geographic context.
11. 2bpartner
Early-stage investor. 2bpartner publishes separate funds and application rules. Its Portuguese presence does not establish that every vehicle can invest in a Lisbon company. Review the current geographic requirements first; only then prepare the business plan and international value-creation case.
Approach: Use the relevant fund’s Candidatura instructions. Official 2bpartner information.
12. Semapa Next
Venture firm. Semapa Next explicitly invests at Series A across defined industrial and software themes. A Lisbon team should bring more than an idea: explain the operating problem, evidence of adoption and the expansion milestone. It is not an interchangeable substitute for a pre-seed angel group.
Approach: Use Submit your pitch. Official Semapa Next information.
13. MSM
Impact venture firm. MSM’s current site links impact and financial performance in the same business model. Show how revenue growth advances the intended outcome, with separate measures for each. Use the current msm.vc identity; the older mustardseedmaze.com domain does not provide reliable current investor information.
Approach: Use the deck/question submission on the current site. Official MSM information.
14. COREangels Lisbon
Angel investment group. COREangels Lisbon has a published early-stage thesis with Portuguese ecosystem, valuation and investment-size conditions. Check those conditions directly before applying. This is one angel group, not a separate count for every member or every COREangels group in another market.
Approach: Use Apply Now on the Lisbon group page. Official COREangels Lisbon information.
15. Seedcamp
Venture firm. Seedcamp adds a wider European research lane for a Lisbon technology company. Explain the product insight and the early evidence appropriate to the round. Treat the regional mandate as a starting point for fit research, not proof that every locally incorporated company qualifies.
Approach: Use the current founder-facing pitch route on the official site. Official Seedcamp information.
A Lisbon ocean-software team builds a first research wave
Fictional worked example. A fictional Lisbon company has built software for monitoring coastal equipment. It has two pilot users, no recurring revenue and a technical demonstration. The proposed round finances paid validation and more reliable deployment. No investor has committed; these are planning assumptions, not a customer result.
| Candidate | Next action | Why it changes the decision |
|---|---|---|
| Faber | Research the climate/ocean or applied-science thesis. | The team can describe a technical result and a clear deployment milestone. |
| Indico | Check the relevant pre-seed technology/ocean route. | The Portuguese connection and MVP are useful, but the specific criteria still matter. |
| EDP Ventures | Approach only if there is a real energy workflow. | Being near the ocean is not evidence of energy-sector fit. |
| Semapa Next / Biovance | Keep outside this immediate queue. | The company is neither a Series A industrial scale-up nor a therapeutic biotech. |
The aim is a more coherent queue, not the largest possible one. Connect the proposed round with an achievable milestone using the round-size planning worksheet.
Build your Lisbon investor-fit worksheet
Use one card for each provider and strategy. It works in a document, spreadsheet or your Finta research notes. Keep facts, expectations and questions in separate fields.
INVESTOR FIT CARD: LISBON
Company, current evidence and next funding milestone: [authorised facts]
Lisbon connection: team office / registered company / customer / research / other
Company lane: software / applied science / ocean-climate / energy / therapeutic biotech
Operating-region or Iberian-team criteria: source and evidence
Founder submission versus LP enquiry: chosen route
Next evidence milestone: product, paying customer, deployment or preclinical result
Investor and specific vehicle: [current name; avoid rebrand duplicates]
Official stage, sector and geographic criteria: [URL; date]
Fit evidence: [what matches; not just a portfolio resemblance]
Mismatch or open question: [the unresolved issue]
Approach route: [founder form / network selection / general enquiry]
Relationship context: [known person; permission to ask; or public route]
Lead/co-investment status: [unknown / conditional / confirmed]
Owner, next action and follow-up date: [person; action; date]Bring the shortlist into Finta to keep investor research, relationship context and follow-up connected. Aurora can help organise the context and prepare a next move for your review. You stay in control of the approach and information shared.
Review your shortlist with Aurora, Claude or Codex
Paste the prompt with the public sources and company information you are authorised to use. Check its output against the sources before acting.
Help me research investor fit for a Lisbon startup.
Company, location, current evidence and funding milestone: [authorised facts]
Candidates and official sources: [names, URLs and research dates]
Separate local offices, regional operating requirements and wider investment eligibility.
Check the specific vehicle, initial stage, sector, company conditions and public approach route.
Keep university programmes, angel networks, direct equity, grants and commercial partnerships distinct.
Count each manager or rebrand once. Do not assume a portfolio investment proves current eligibility.
Return a table: source, fit evidence, mismatch, unknown, next question and owner.
Flag missing or contradictory evidence instead of filling gaps.
Suggest a short first research wave and explain exclusions.
Do not contact anyone, submit forms or share confidential information.Keep the wider fundraising process connected with the pre-seed guide, Seed Fundraising Comprehensive Guide and investor-prospecting workflow. For national coverage, see the Portugal investor guide.
Methodology and research date
By Finta Editorial Team. Official investor, public-institution and company materials reviewed November 13, 2026, with source-dated prior research used for discovery. 15 provider families are included: 10 documented local or regional routes and 5 wider mandates. Angel networks are identified as networks, not pooled funds. Company-building and strategic investment routes are labelled separately.
Startup Genome’s 2026 Emerging Ecosystems ranking informed city selection; it is not an investor ranking or endorsement. Current official materials support the profiles. A published thesis is not a promise of available capital, current intake or an investment outcome. Confirm open questions directly.
Not counted or kept separate:
- The former mustardseedmaze.com domain is not used as current investor evidence; MSM’s current official site is msm.vc.
- Bionova is not counted as an additional active investor; the relevant current therapeutic route is Biovance.
General information, not personalised financial, legal or tax advice. Programme and company criteria are research filters, not an eligibility ruling. The cover is an editorial ecosystem illustration, not a map of investor offices or actual financing flows.